SciELO - Scientific Electronic Library Online

 
vol.18 número2Enfoques mucosales en vacunologia de NeisseriaLas vacunas conjugadas contra la enfermedad meningococica causadas por los serogrupos A, C, W-135, Y índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Vaccimonitor

versión impresa ISSN 1025-028Xversión On-line ISSN 1025-0298

Resumen

MILLER, Jacqueline; POOLMAN, Jan  y  BOUTRIAU, Dominique. The New Generation of Meningococcal Conjugate Vaccines: Rationale and Global Potential. Vaccimonitor [online]. 2009, vol.18, n.2, pp.58-60. ISSN 1025-028X.

The serogroup distribution of Neisseria meningitidis strains implicated in invasive disease varies geographically and temporally. Monovalent serogroup C conjugate vaccines have successfully reduced serogroup C disease in countries where they are used. However, combinations containing multiple serogroups are needed to fully address disease prevention. GlaxoSmithKline Biologicals’ combined serogroups C, Y and Haemophilus influenzae type b conjugate vaccine (Hib-MenCY-TT) has been shown to be immunogenic and well tolerated in infants. The novel Hib-MenCY-TT vaccine has the potential to prevent approximately 90% of non-serogroup B disease in the US. Several manufacturers have investigated tetravalent ACWY conjugate vaccines. One ACWY conjugate vaccine has been licensed for use 2-55 year olds, but the immunogenicity in infants was reduced. Results of other ACWY vaccines using different protein conjugates have shown higher immunogenicity in infants. The next generation of combination meningococcal conjugate vaccines has potential to further reduce morbidity and mortality due to N. meningitidis, provided they are safe and immunogenic in infants and toddlers. A Hib-MenCY-TT vaccine could substantially reduce meningococcal disease in the US, while tetravalent ACWY conjugate vaccines have the potential to provide coverage across age strata against four of the five major serotypes implicated in invasive meningococcal disease.

Palabras clave : Meningitis; Neisseria meningitidis; vaccine; primary vaccination.

        · texto en Inglés     · Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons